USS Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

USS Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,654	Closed	-$818K	–	600
2022 Q2	$818K	Sell	1,654 -336	-17%	-$175K	0.01%	629
2022 Q1	$1.12M	Sell	1,990 -2,933	-60%	-$1.77M	0.01%	637
2021 Q4	$3.72M	Hold	4,923	–	–	0.03%	520
2021 Q3	$3.67M	Buy	4,923 +3,531	+254%	+$2.65M	0.03%	510
2021 Q2	$896K	Hold	1,392	–	–	0.01%	537
2021 Q1	$795K	Hold	1,392	–	–	0.01%	529
2020 Q4	$812K	Hold	1,392	–	–	0.01%	520
2020 Q3	$717K	Hold	1,392	–	–	0.01%	513
2020 Q2	$628K	Buy	+1,392	New	+$614K	0.01%	524

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

USS Investment Management's BIO Position: Q3 2022 in Review

USS Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 1,654 shares — an estimated $818K sold.

USS Investment Management first reported a position in BIO in Q2 2020 and held it in 9 quarters. The position peaked at $3.72M in Q4 2021. 485 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

USS Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
USS Investment Management sold 1,654 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $818K.
USS Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 9 quarters.
USS Investment Management's Bio-Rad Laboratories Class A position peaked at $3.72M in Q4 2021.
485 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on USS Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.